News from us and our partners

Tags

Topics

0 results

News
7 September, 2023
Abivax provides business and operational update
News
6 September, 2023
HighLife launches a new Large Annulus Valve in ongoing clinical studies for patients suffering from Mitral Regurgitation
News
29 August, 2023
Cécile Dupont, Sofinnova MD Start Partner, selected as In Vivo Rising Leader
News
25 August, 2023
Brits call for tech revolution to tackle NHS wait times, deepc joins forces with BT
News
23 August, 2023
World’s first cancer patient treated with RefleXion’s breakthrough SCINTIX biology-guided radiotherapy
News
22 August, 2023
Recor Medical and Otsuka Medical Devices announce positive vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the treatment of hypertension
News
21 August, 2023
Abivax secures up to €150M in structured debt financing
News
15 August, 2023
Sitryx appoints Carrie Cook as Chief Business Officer
News
3 August, 2023
Sensorion completes a private placement of €35 million subscribed by leading US and European biotech investors
News
3 August, 2023
GenSight Biologics obtains funding of €10 million from Sofinnova Partners, Invus and UPMC Enterprises
News
3 August, 2023
Sofinnova Partners’ focus on people and science at the core of investment strategy
News
24 July, 2023
Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumors
News
20 July, 2023
Sangamo and nChroma partner on zinc finger epigenetic editing
News
19 July, 2023
Sensorion submits Clinical Trial Application for OTOF-GT, its lead gene therapy candidate, in Europe
News
12 July, 2023
Tenpoint Therapeutics launches with $70 million Series A financing to reverse vision loss through engineered cell-based therapeutics and in vivo reprogramming
News
11 July, 2023
NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor

Abivax provides business and operational update

HighLife launches a new Large Annulus Valve in ongoing clinical studies for patients suffering from Mitral Regurgitation

Cécile Dupont, Sofinnova MD Start Partner, selected as In Vivo Rising Leader

Brits call for tech revolution to tackle NHS wait times, deepc joins forces with BT

World’s first cancer patient treated with RefleXion’s breakthrough SCINTIX biology-guided radiotherapy

Recor Medical and Otsuka Medical Devices announce positive vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the treatment of hypertension

Abivax secures up to €150M in structured debt financing

Sitryx appoints Carrie Cook as Chief Business Officer

Sensorion completes a private placement of €35 million subscribed by leading US and European biotech investors

GenSight Biologics obtains funding of €10 million from Sofinnova Partners, Invus and UPMC Enterprises

Sofinnova Partners’ focus on people and science at the core of investment strategy

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumors

Sangamo and nChroma partner on zinc finger epigenetic editing

Sensorion submits Clinical Trial Application for OTOF-GT, its lead gene therapy candidate, in Europe

Tenpoint Therapeutics launches with $70 million Series A financing to reverse vision loss through engineered cell-based therapeutics and in vivo reprogramming

NodThera is first to demonstrate reduction in neuroinflammation in the clinic with brain penetrant NLRP3 inflammasome inhibitor